Ryon P Graf

29PUBLICATIONS
165CO-AUTHORS
Predictive and prognostic markersMolecular targetsLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Sep 09, 2026
Prospective Evaluation of Circulating Tumor DNA in Metastatic Hormone-Sensitive Prostate Cancer.

|Aug 14, 2026
Clinical, genomic, and spatial transcriptomic features of pancreatic adenosquamous carcinoma support subtype-specific therapeutic strategies.

|Aug 13, 2026
SPEN inactivation drives resistance to androgen receptor pathway inhibitors in metastatic prostate cancer.

|Jul 10, 2026
Endometrial Cancer by ERBB2 Amplification (ERBB2amp) Status: Differences in Molecular Subtypes, Ancestry, and Real-World Outcomes.

|May 14, 2026
Homozygous Loss of Recombination Repair Genes and Poly ADP-Ribose Polymerase Inhibitor Benefit for Patients With Ovarian Cancer.

|Mar 31, 2026
Clinical value of tumor mutational burden for neoadjuvant and adjuvant immune checkpoint inhibitor in early-stage non-small cell lung cancer.

Julia C F Quintanilha, Gerald Li, Ryon P Graf

Pageof 5

Frequent Collaborators

11 joint publications

Gerald Li

10 joint publications

Geoffrey R Oxnard

10 joint publications

Richard Sheng Poe Huang

8 joint publications

Jeffrey S Ross